A Trial of Immunological Outcomes of Sublingual Immunotherapy for House Dust Mite (D. Pteronyssinus) Allergy

NCT00250263 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER_GOV

Sponsor class

Conditions

Allergic Rhinitis
Asthma

Interventions

DRUG: (agent for immunotherapy) Staloral
DRUG: Placebo

Sponsor

Bayside Health